Monografie
Multivalent antibody-scTRAIL fusion proteins for tumor therapy : impact of format and targeting
- Sprache
-
Englisch
- Identifier
-
1130657035
Thema
Krebs; Onkologie; Hochschulschrift
Beteiligte Personen und Organisationen
- DOI
-
10.18419/opus-9095
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:53 MEZ
Objekttyp
- Monografie
Beteiligte
- Hutt, Meike
- Kontermann, Roland
Ähnliche Objekte (12)
Generation of colo rectal cancer targeting TRAIL fusion proteins and a mesenchymal stem cell line for in situ expression of these proteins
Generation of "LYmph Node Derived Antibody Libraries" (LYNDAL) : a concept for recovering human monoclonal antibodies with therapeutic potential
Characterization of TRAIL-mediated apoptotic pathways in the lung cancer cell line NCI-H460 with focus on caspase-3 and XIAP
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Deleted in Liver Cancer 3 (DLC3) in the regulation of junctional Rho signaling and cell polarity
Die Rolle des p53-Status für die Sensitivität von Tumoren gegenüber unterschiedlichen p53 Aktivatoren
Bifunctional immunostimulatory fusion proteins for therapeutic applications
TRAIL-based multivalent and multifunctional fusion proteins and liposomes for therapeutic applications
Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism
IL-15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands for cancer immunotherapy
Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex
Combinations of costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy
Generation of colo rectal cancer targeting TRAIL fusion proteins and a mesenchymal stem cell line for in situ expression of these proteins
Generation of "LYmph Node Derived Antibody Libraries" (LYNDAL) : a concept for recovering human monoclonal antibodies with therapeutic potential
Characterization of TRAIL-mediated apoptotic pathways in the lung cancer cell line NCI-H460 with focus on caspase-3 and XIAP
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Deleted in Liver Cancer 3 (DLC3) in the regulation of junctional Rho signaling and cell polarity
Die Rolle des p53-Status für die Sensitivität von Tumoren gegenüber unterschiedlichen p53 Aktivatoren
Bifunctional immunostimulatory fusion proteins for therapeutic applications
TRAIL-based multivalent and multifunctional fusion proteins and liposomes for therapeutic applications
Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism
IL-15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands for cancer immunotherapy
Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex
Combinations of costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy
Generation of colo rectal cancer targeting TRAIL fusion proteins and a mesenchymal stem cell line for in situ expression of these proteins
Generation of "LYmph Node Derived Antibody Libraries" (LYNDAL) : a concept for recovering human monoclonal antibodies with therapeutic potential
Characterization of TRAIL-mediated apoptotic pathways in the lung cancer cell line NCI-H460 with focus on caspase-3 and XIAP
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Deleted in Liver Cancer 3 (DLC3) in the regulation of junctional Rho signaling and cell polarity
Die Rolle des p53-Status für die Sensitivität von Tumoren gegenüber unterschiedlichen p53 Aktivatoren
Bifunctional immunostimulatory fusion proteins for therapeutic applications
TRAIL-based multivalent and multifunctional fusion proteins and liposomes for therapeutic applications
Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism
IL-15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands for cancer immunotherapy
Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex